Use of Engineered Regulatory T-Cells to Induce Immunologic Tolerance: Path to the Clinic
Time: 11:30 am
day: Focus Day - Track A - Afternoon
Details:
- Rational and preliminary data to support the use of antigen-specific Tregs as a therapeutic approach
- Engineering technologies to improve Treg efficacy in the clinical application
